Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,510 | 29,766 | 37,131 | 26,514 | 43,288 |
| Marketable Securities | 178,438 | 215,916 | 238,766 | 273,646 | 280,916 |
| Receivables | 11,549 | 16,508 | 11,747 | 4,567 | 6,628 |
| TOTAL | $239,097 | $265,591 | $293,022 | $309,068 | $334,471 |
| Non-Current Assets | |||||
| PPE Net | 25,339 | 24,699 | 24,395 | 22,383 | 21,400 |
| Intangibles | 5,385 | 5,650 | 5,915 | 6,181 | 6,446 |
| Other Non-Current Assets | 20,875 | 20,875 | 20,875 | 20,127 | 20,371 |
| TOTAL | $51,599 | $51,224 | $51,185 | $48,691 | $48,217 |
| Total Assets | $290,696 | $316,815 | $344,207 | $357,759 | $382,688 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,854 | 6,307 | 6,194 | 2,751 | 3,643 |
| Accrued Expenses | 10,024 | 11,447 | 11,774 | 9,554 | 7,299 |
| Other current liabilities | 477 | 496 | 479 | 290 | 372 |
| TOTAL | $19,200 | $21,942 | $22,885 | $16,829 | $15,890 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,845 | 3,692 | 4,438 | 4,234 | 4,576 |
| Other Non-Current Liabilities | 915 | 1,012 | 1,074 | 602 | 657 |
| TOTAL | $23,745 | $25,036 | $25,334 | $26,014 | $26,753 |
| Total Liabilities | $42,945 | $46,978 | $48,219 | $42,843 | $42,643 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,745 | 52,476 | 52,298 | 52,285 | 51,925 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -297,821 | -270,459 | -240,398 | -215,016 | -186,167 |
| Other shareholders' equity | 9 | 25 | 120 | 22 | 46 |
| TOTAL | $247,751 | $269,837 | $295,988 | $314,916 | $340,045 |
| Total Liabilities And Equity | $290,696 | $316,815 | $344,207 | $357,759 | $382,688 |